the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

KDN studying amending Act 298 – Saifuddin

KUALA LUMPUR: The Home Ministry (KDN) is looking into several measures to improve aspects of national security, including amending the Protected Areas and Protected Places Act 1959 (Act 298).

Its minister, Datuk Seri Saifuddin Nasution Ismail said the law has never been amended since it was introduced in 1959 and no longer meets the current situation.

“This law has never been improved and in moving forward, we need to focus on several things such as aspects of punitive value and the broadening of powers involving various enforcement agencies.

“We can no longer have only one agency be given authority, there must be various agencies to enforce it. The focus is on the punitive aspect,” he told reporters at the 2023 Important Target Star Rating Awards Appreciation Ceremony here today.

Also present were the Home Ministry Secretary-General Datuk Ruji Ubi and Internal Security and Public Order Director Datuk Seri Hazani Ghazali.

According to Saifuddin, the study on the proposed amendments to the act has been carried out since last year.

He said other actions taken by the ministry to improve aspects of national security included working on a new bill related to cyber security and the implementation of the Single Border Agency (SBA), scheduled in the first quarter of next year.

The implementation of SBA is aimed at ensuring an efficient delivery system at border checkpoints without unnecessary complexities, he said, adding that it was also geared towards ensuring effective coordination at the border and aims to enhance the integrity of officers.–Bernamapix

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings